title: Evaluation of two commercial human T-cell lymphotropic virus western blot (immunoblot) kits with problem specimens.
abstract: We evaluated two commercial human T-cell lymphotropic virus (HTLV) Western blot (WB; immunoblot) kits, Cambridge Biotech Corp. (CBC) and Diagnostic Biotechnology Ltd. (DBL). Both methods employ HTLV type I (HTLV-I) viral lysate and rgp21. The DBL WB kit also distinguishes between HTLV-I and HTLV-II antibodies, using an HTLV-I-specific and an HTLV-II-specific recombinant. Fifty weakly reactive HTLV-II-positive plasma specimens which were falsely negative with the Abbott enzyme immunoassay (EIA) and 50 Ortho EIA false-positive samples were selected to determine sensitivity and specificity. The sensitivities of the CBC and the DBL WB kits were 90 and 68%, respectively. All positive samples reacted with rgp21 in both kits, but some did not display core bands. Five samples were typed as HTLV-I and four were typed as dual infection by the DBL WB kit. The specificities of the CBC and DBL kits were 48 and 70%, respectively. The most prevalent WB reaction with the negative samples was with the core protein, p19, followed by p24 and p28 for CBC and rgp21 and p28 for DBL. DBL had two false-positive interpretations, and CBC had none, rgp21 was the most sensitive antigen in both kits for the weakly reactive HTLV-II samples. If all samples not reacting with this protein were interpreted as WB negative, regardless of other bands, the specificity would improve to 90% for CBC and 86% for DBL.
authors: Viral and Rickettsial Disease Laboratory, State of California Department of Health Services, Berkeley 94704.
authors: D
authors: D
authors: Gallo
authors: J L
authors: JL
authors: Diggs
authors: C V
authors: CV
authors: Hanson
mesh_terms: D015153:Blotting, Western; D015480:Deltaretrovirus Antibodies / Q000097:blood* / Q000276:immunology; D005069:Evaluation Studies as Topic; D005188:False Negative Reactions; D005189:False Positive Reactions; D015686:Gene Products, env / Q000276:immunology*; D015368:Human T-lymphotropic virus 1 / Q000276:immunology*; D015367:Human T-lymphotropic virus 2 / Q000276:immunology*; D006801:Humans; D016133:Polymerase Chain Reaction; D011933:Reagent Kits, Diagnostic; D015682:Retroviridae Proteins, Oncogenic / Q000276:immunology*; D012680:Sensitivity and Specificity; D054299:env Gene Products, Human Immunodeficiency Virus
chemical_list: D015480:Deltaretrovirus Antibodies; D015686:Gene Products, env; D011933:Reagent Kits, Diagnostic; D015682:Retroviridae Proteins, Oncogenic; D054299:env Gene Products, Human Immunodeficiency Virus; C055265:gp21 protein, Human T-lymphotropic virus 1; C069569:human T-cell leukemia virus type-II protein gp21